Emergency pill for West, pharma giant India's arrives

JUST A PHARM-ALITY: But India is seen as a better venue for chemistry.

ibnlive.com is on mobile now. Read news, watch videos
be a Citizen Journalist. Log on to m.ibnlive.com NOW!

Top Headlines

Top Videos

Most Popular

• I took calculated risks for higher growth: Pranab  

• Udayan's View: Budget 2009, a game of patience 

• A study in comparison: Education budget up Rs 7K cr 

• Face The Budget: Political response to Budget 09-10 

• The verdict: CNN-IBN panelists rate Pranab's Budget  

• Reform hopes dashed, market watchers feel let down  

• I-T exemption limit raised | FBT rolled back | Taxes and you 

• Pranab skips two paras of Budget speech, apologises 

• Bengal benefits, Mamata and Pranab budget for their state 

• Income tax limits raised; farmers, exporters get sops 

• Watch: Dalal Street reacts to the Budget 

• Budget: Pranab's chance to create his own legacy 

• FM has done a fairly good job: Narayana Murthy 

• Budget to focus on social spend, growth 

• Education reform will be for all Indians: Sibal 

• The Budget That Isn't: Cyrus gears up for Budget 

• EVMs are tamper proof, says Election Commission 

• Watch: Railway exams disrupted in Mysore, Banglaore 

• Watch: Maneka writes to PM over threat to Varun's life 

• One-upmanship: Sonia, Pawar in foodgrain politics 

• Life saving drugs, LCDs cheaper; Set-top-box costlier 

• Buy that big car: SUVs, petrol trucks to cost less 

• Defence budget unchanged; Army gets lion's share 

• Minimum Rs 30 lakh needed to be called wealthy 

• TAX BREAKS, WELFARE SCHEMES IN COMMON MAN'S BUDGET 

• Common man gets a treat, over 15 schemes 

• Health budget up by Rs 4,000 cr, 6 new AIIMS in cities 

• Bengal benefits, Mamata and Pranab budget for their state 

• Full text: Union Budget 2009 

• Software industry gets tax benefits for one more yr 

Photogallery

Find us on Facebook | Join IBNLive community

Stay ahead with G-Talk Buddy | Click now!

New York: In 2006, five-and-a-half percent of all global pharma patent applications listed one or more inventors from India, a fourfold jump from 1995.

India is emerging as a destination for high value R&D alongside the lower value manufacturing and clinical trial work for western pharmaceutical giants, says a study by US based academic Vivek Wadhwa.

“The Indian companies are really, really smart. They are looking at a very large generics market but they have also realised that they can now become the R&D capital of the world, so what they are doing now is they are looking for opportunities to assist American big pharma in developing sophisticated new drugs and also they are doing their own drug discovery,” he says.

The study found China leads India as the preferred destination for clinical trials, animal experimentation and manufacturing. But India is seen as a better venue for chemistry and drug discovery activities.

China produces 10 times as many Ph Ds in science and engineering as India.

But as Indian companies have the most experience in selling generic drugs that meet FDA standards, India is playing a bigger role for western companies in drug research and development and could soon emerge as a major powerhouse in its own right.